Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2023 Earnings

3AugConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-14.36

-11.9

-9.44

-6.98

Details

Expected EPS

-7.374600000000001

Actual EPS

-10.865244

Surprise EPS

-3.49

Surprise Percent

+47.33%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -10.865244 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.